UNSPSC 51123709: Berlafenone

This classification denotes an antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 4MYE3XA3GV. European Medicines Agency schedules Berlafenone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05781MIG. Berlafenone generally arises in the molecular formula C19H25NO2.

UNSPSC 51123709 Berlafenone, a Commodity code, does not align with the recent state and local procurement activity posted under it. The single recent opportunity in the dataset — City of Tampa Purchasing Department IFB 26P00188, posted April 24, 2026, due April 8, 2026 — solicits Advanced Life Support Medications (Labetalol HCI, Epinephrine, Adenosine, and Diltiazem) for Tampa Fire Rescue in Hillsborough County, Florida, with an estimated contract value of $40,000.00. None of these medications are berlafenone, and the code designation appears to be a data entry or classification error rather than a signal of active market demand for this specific pharmaceutical commodity.

The Tampa Fire Rescue bid is the only recent state and local opportunity under this code in the source material. The solicitation follows standard municipal procurement protocols — sealed bid through OpenGov eProcurement Portal, firm pricing with all shipping included, one-year initial term with two one-year renewal options plus three 30-day unilateral extension periods, a 5 percent Small Local Business Enterprise bid discount (not to exceed $10,000), and full compliance with OSHA Hazard Communication Standards and WCAG 2.2 accessibility requirements. Without additional recent opportunities under this code from other jurisdictions or states, no pattern of buying behavior, geographic concentration, or repeat issuing bodies can be identified. Firms pursuing pharmaceutical supply contracts with Florida municipalities and emergency services should monitor the code for reclassification or correction, though the current listing offers minimal evidence of sustained state and local demand for berlafenone specifically.